ENDRA Life Sciences NDRA Stock
ENDRA Life Sciences Price Chart
ENDRA Life Sciences NDRA Financial and Trading Overview
| ENDRA Life Sciences stock price | 5.61 USD |
| Previous Close | 5.5 USD |
| Open | 5.91 USD |
| Bid | 4.11 USD x 200 |
| Ask | 7.06 USD x 200 |
| Day's Range | 5.32 - 5.91 USD |
| 52 Week Range | 2.96 - 9.85 USD |
| Volume | 78.16K USD |
| Avg. Volume | 30.44K USD |
| Market Cap | 6.86M USD |
| Beta (5Y Monthly) | -0.054 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25 USD |
NDRA Valuation Measures
| Enterprise Value | 7.09M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.7763158 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.75 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.103 |
Trading Information
ENDRA Life Sciences Stock Price History
| Beta (5Y Monthly) | -0.054 |
| 52-Week Change | -31.84% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 9.85 USD |
| 52 Week Low | 2.96 USD |
| 50-Day Moving Average | 5.07 USD |
| 200-Day Moving Average | 4.94 USD |
NDRA Share Statistics
| Avg. Volume (3 month) | 30.44K USD |
| Avg. Daily Volume (10-Days) | 31.61K USD |
| Shares Outstanding | 1.27M |
| Float | 1.2M |
| Short Ratio | 0.9 |
| % Held by Insiders | 8.73% |
| % Held by Institutions | 9.66% |
| Shares Short | 42.12K |
| Short % of Float | 3.50% |
| Short % of Shares Outstanding | 3.31% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -122.32% |
| Return on Equity (ttm) | -412.59% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -6427816 USD |
| Net Income Avi to Common (ttm) | -7302513 USD |
| Diluted EPS (ttm) | -7.91 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 356.46K USD |
| Total Cash Per Share (mrq) | 0.28 USD |
| Total Debt (mrq) | 461.21K USD |
| Total Debt/Equity (mrq) | 25.81 USD |
| Current Ratio (mrq) | 0.642 |
| Book Value Per Share (mrq) | 1.44 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5009079 USD |
| Levered Free Cash Flow (ttm) | -5423062 USD |
Profile of ENDRA Life Sciences
| Country | United States |
| State | MI |
| City | Ann Arbor |
| Address | 3600 Green Court |
| ZIP | 48105-1570 |
| Phone | 734 335 0468 |
| Website | https://endrainc.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Q&A For ENDRA Life Sciences Stock
What is a current NDRA stock price?
ENDRA Life Sciences NDRA stock price today per share is 5.61 USD.
How to purchase ENDRA Life Sciences stock?
You can buy NDRA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ENDRA Life Sciences?
The stock symbol or ticker of ENDRA Life Sciences is NDRA.
Which industry does the ENDRA Life Sciences company belong to?
The ENDRA Life Sciences industry is Diagnostics & Research.
How many shares does ENDRA Life Sciences have in circulation?
The max supply of ENDRA Life Sciences shares is 1.27M.
What is ENDRA Life Sciences Price to Earnings Ratio (PE Ratio)?
ENDRA Life Sciences PE Ratio is now.
What was ENDRA Life Sciences earnings per share over the trailing 12 months (TTM)?
ENDRA Life Sciences EPS is -8.16 USD over the trailing 12 months.
Which sector does the ENDRA Life Sciences company belong to?
The ENDRA Life Sciences sector is Healthcare.
ENDRA Life Sciences NDRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26269.23 USD — |
+0.62
|
6.33B USD — | 26041.13 USD — | 26316.81 USD — | — - | 6.33B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
140.4 USD — |
+0.07
|
— — | 138.5 USD — | 141.42 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1251.97 USD — |
+0.86
|
— — | 1233.72 USD — | 1252.49 USD — | — - | — — |
- {{ link.label }} {{link}}